Gowling WLG advises Chinese private equity funds on Series A financing in Rostrum Medical Innovations Inc.

02 August 2016
Client work

On August 2, 2016, Shanghai Yongju Private Equity Limited Partnership and Shanghai Yikang Private Equity Limited Partnership completed a Series A financing in Rostrum Medical Innovations Inc., a medical device company developing and commercializing respiratory enthalpy measurement devices.

Gowling WLG advised the investors with a team that included Jack Yong, Lorena Vlad, Pablo Tseng and Marcus Ostrowerka.

NOT LEGAL ADVICE. Information made available on this website in any form is for information purposes only. It is not, and should not be taken as, legal advice. You should not rely on, or take or fail to take any action based upon this information. Never disregard professional legal advice or delay in seeking legal advice because of something you have read on this website. Gowling WLG professionals will be pleased to discuss resolutions to specific legal concerns you may have.
Related   Financial Institutions & Services, Corporate Commercial

Related Insights & Resources

View all insights Related Insights & Resources
Client work
17 April 2024 Rio2 closes $23 million offering
Client work
07 March 2024 ATHA Energy and Latitude Uranium complete merger
Client work
06 March 2024 CIB and FNBC announce first-of-its-kind loan product to increase accessibility to infrastructure financing for Indigenous communities
Download or print PDF